Breakthrough in cancer treatment: a personalized vaccine made for each patient and their tumor
For the first time, an mRNA-based treatment tailored to the mutations in each patient’s tumor has met the endpoints of a phase 3 trial in melanoma. The vaccine was given alongside Keytruda, and researchers are now awaiti
119